These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 19808597

  • 1. Comparison of gadofluorine-M and Gd-DTPA for noninvasive staging of atherosclerotic plaque stability using MRI.
    Ronald JA, Chen Y, Belisle AJ, Hamilton AM, Rogers KA, Hegele RA, Misselwitz B, Rutt BK.
    Circ Cardiovasc Imaging; 2009 May; 2(3):226-34. PubMed ID: 19808597
    [Abstract] [Full Text] [Related]

  • 2. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability.
    Sirol M, Moreno PR, Purushothaman KR, Vucic E, Amirbekian V, Weinmann HJ, Muntner P, Fuster V, Fayad ZA.
    Circ Cardiovasc Imaging; 2009 Sep; 2(5):391-6. PubMed ID: 19808627
    [Abstract] [Full Text] [Related]

  • 3. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging.
    Sirol M, Itskovich VV, Mani V, Aguinaldo JG, Fallon JT, Misselwitz B, Weinmann HJ, Fuster V, Toussaint JF, Fayad ZA.
    Circulation; 2004 Jun 15; 109(23):2890-6. PubMed ID: 15184290
    [Abstract] [Full Text] [Related]

  • 4. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging.
    Barkhausen J, Ebert W, Heyer C, Debatin JF, Weinmann HJ.
    Circulation; 2003 Aug 05; 108(5):605-9. PubMed ID: 12835227
    [Abstract] [Full Text] [Related]

  • 5. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.
    Yasuda S, Ikuta K, Uwatoku T, Oi K, Abe K, Hyodo F, Yoshimitsu K, Sugimura K, Utsumi H, Katayama Y, Shimokawa H.
    J Vasc Res; 2008 Aug 05; 45(2):123-8. PubMed ID: 17940339
    [Abstract] [Full Text] [Related]

  • 6. Tropoelastin: A novel marker for plaque progression and instability.
    Phinikaridou A, Lacerda S, Lavin B, Andia ME, Smith A, Saha P, Botnar RM.
    Circ Cardiovasc Imaging; 2018 Aug 05; 11(8):. PubMed ID: 30214669
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI.
    Cornily JC, Hyafil F, Calcagno C, Briley-Saebo KC, Tunstead J, Aguinaldo JG, Mani V, Lorusso V, Cavagna FM, Fayad ZA.
    J Magn Reson Imaging; 2008 Jun 05; 27(6):1406-11. PubMed ID: 18504763
    [Abstract] [Full Text] [Related]

  • 8. Gadofluorine M-enhanced magnetic resonance imaging of inflammatory bowel disease: quantitative analysis and histologic correlation in a rat model.
    Frericks BB, Kühl AA, Loddenkemper C, Stroux A, Valdeig S, Hotz B, Misselwitz B, Hoffmann JC, Wacker FK.
    Invest Radiol; 2011 Aug 05; 46(8):478-85. PubMed ID: 21512398
    [Abstract] [Full Text] [Related]

  • 9. Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.
    Calcagno C, Cornily JC, Hyafil F, Rudd JH, Briley-Saebo KC, Mani V, Goldschlager G, Machac J, Fuster V, Fayad ZA.
    Arterioscler Thromb Vasc Biol; 2008 Jul 05; 28(7):1311-7. PubMed ID: 18467641
    [Abstract] [Full Text] [Related]

  • 10. Use of contrast enhancement and high-resolution 3D black-blood MRI to identify inflammation in atherosclerosis.
    Hur J, Park J, Kim YJ, Lee HJ, Shim HS, Choe KO, Choi BW.
    JACC Cardiovasc Imaging; 2010 Nov 05; 3(11):1127-35. PubMed ID: 21071000
    [Abstract] [Full Text] [Related]

  • 11. Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.
    Burtea C, Laurent S, Murariu O, Rattat D, Toubeau G, Verbruggen A, Vansthertem D, Vander Elst L, Muller RN.
    Cardiovasc Res; 2008 Apr 01; 78(1):148-57. PubMed ID: 18174291
    [Abstract] [Full Text] [Related]

  • 12. Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques.
    Ronald JA, Chen JW, Chen Y, Hamilton AM, Rodriguez E, Reynolds F, Hegele RA, Rogers KA, Querol M, Bogdanov A, Weissleder R, Rutt BK.
    Circulation; 2009 Aug 18; 120(7):592-9. PubMed ID: 19652086
    [Abstract] [Full Text] [Related]

  • 13. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J, Ochoa E, Misselwitz B, Yang D, El Naqa I, Woodard PK, Abendschein D.
    Invest Radiol; 2008 Jan 18; 43(1):49-55. PubMed ID: 18097277
    [Abstract] [Full Text] [Related]

  • 14. Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels.
    Fink C, Puderbach M, Ley S, Plathow C, Bock M, Zuna I, Kauczor HU.
    Invest Radiol; 2004 Mar 18; 39(3):143-8. PubMed ID: 15076006
    [Abstract] [Full Text] [Related]

  • 15. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
    Calcagno C, Lairez O, Hawkins J, Kerr SW, Dugas MS, Simpson T, Epskamp J, Robson PM, Eldib M, Bander I, K-Raman P, Ramachandran S, Pruzan A, Kaufman A, Mani V, Ehlgen A, Niessen HG, Broadwater J, Fayad ZA.
    JACC Cardiovasc Imaging; 2018 Feb 18; 11(2 Pt 2):291-301. PubMed ID: 29413439
    [Abstract] [Full Text] [Related]

  • 16. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
    Ryeom HK, Kim SH, Kim JY, Kim HJ, Lee JM, Chang YM, Kim YS, Kang DS.
    Korean J Radiol; 2004 Feb 18; 5(4):231-9. PubMed ID: 15637473
    [Abstract] [Full Text] [Related]

  • 17. Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque.
    Phinikaridou A, Andia ME, Lavin B, Smith A, Saha P, Botnar RM.
    Circ Cardiovasc Imaging; 2016 Dec 18; 9(12):. PubMed ID: 27940955
    [Abstract] [Full Text] [Related]

  • 18. Contrast enhancement by lipid-based MRI contrast agents in mouse atherosclerotic plaques; a longitudinal study.
    den Adel B, van der Graaf LM, Que I, Strijkers GJ, Löwik CW, Poelmann RE, van der Weerd L.
    Contrast Media Mol Imaging; 2013 Dec 18; 8(1):63-71. PubMed ID: 23109394
    [Abstract] [Full Text] [Related]

  • 19. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases.
    Hyafil F, Vucic E, Cornily JC, Sharma R, Amirbekian V, Blackwell F, Lancelot E, Corot C, Fuster V, Galis ZS, Feldman LJ, Fayad ZA.
    Eur Heart J; 2011 Jun 18; 32(12):1561-71. PubMed ID: 21118852
    [Abstract] [Full Text] [Related]

  • 20. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
    Schnorr J, Wagner S, Ebert W, Heyer C, Laub G, Kivelitz D, Abramjuk C, Hamm B, Taupitz M.
    Rofo; 2003 Jun 18; 175(6):822-9. PubMed ID: 12811696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.